Cancer-related Fatigue and the Additive Effect of Treatment in the Context of Lymphoma: An Analysis of the Lymphoma Coalition's 2022 Global Patient Survey.
Steve E KallogerAmanda WatsonShawn SajkowskiLorna WarwickPublished in: Cancer research communications (2024)
CRF is a highly incident phenomenon in lymphoma that can be ascribed to a combination of causes. We have demonstrated substantial variability across various subtypes of lymphoma and have estimated that nearly half of the reported fatigue comes from treatment. Increased screening for and monitoring of fatigue will yield favorable health-related quality of life that will benefit health technology assessment activities and yield improved outcomes for patients.
Keyphrases
- diffuse large b cell lymphoma
- end stage renal disease
- healthcare
- sleep quality
- cardiovascular disease
- chronic kidney disease
- public health
- mental health
- cross sectional
- type diabetes
- metabolic syndrome
- adipose tissue
- risk assessment
- insulin resistance
- combination therapy
- skeletal muscle
- health information
- replacement therapy
- health promotion